- Giants
- Social Capital
- GLP-1 drug revenue comparison
GLP-1 drug revenue comparison
Social Capital's line chart drew 92.9K views on X: 23x its typical post and #27 of 41 Social Capital charts we track by views. Read Oct 14, 2026.
In 2025, the two biggest GLP-1 drugs generated ~2x the combined revenue of OpenAI and Anthropic.
Why it spread
This post from @socialcapital in the vc category spread because it earned 216 likes, 16 reposts, 10 quotes, and 55 saves against 20,764 views, which is 30.9 times the account's typical 7 likes, and the main reasons were many quotes and polished design.
What worked
- The framing contrasts two well known categories, GLP-1 drugs and AI companies, in a single line chart that shows GLP-1 drug revenues surpass AI companies.
- The post is branded and includes a source line, which supports credibility even though source reach sits in the bottom quarter.
- Quote rate lands in the top quarter, meaning people did not just like it, they argued with it or amplified it in their own words.
What to borrow
We could take a comparison our audience already holds strong opinions about talents, budgets, or market sizes and show one line crossing another, then label the axes ourselves so the takeaway is readable without a caption.
Careful
Do not over-read the low unusual form and medium design polish as the driver, and do not assume the same framing will travel for us just because it did here, since the account already had a large audience and the source reach was only in the bottom quarter.
Written by our analysis model from the measured numbers above, not by Social Capital.
Make it yours
Your numbers, in this line chart.
Starts from the real numbers of "Revenue from the two biggest GLP-1 drugs vs. OpenAI and Anthropic" by Social Capital. Replace every number with yours before you post. Make one like this, step by step
Free pictures carry a small "Made with ViralChart" line. That line is how other people find us.
API · Max
Use this chart via API
On the Max plan you can pull this chart's numbers with the provenance of each one, as JSON or CSV, with its redraw spec, or call it from an agent over MCP. Chart id 09e899079ad4.
| Path | Returns | Plan | |
|---|---|---|---|
| GET | /api/v1/charts/09e899079ad4 | Title, publisher, date, form, point count; with a Max key, the data link | Open |
| GET | /api/v1/charts/09e899079ad4/data | Every point with its provenance and confidence, plus the redraw spec. Add ?format=csv for CSV | Max |
| GET | /api/v1/charts/09e899079ad4/render?view=1 | The draw-only view this page uses | Open |
| POST | /mcp | Tool get_chart_data with this id, for Claude, Cursor and other agents | Max |
curl -s https://viral-chart.com/api/v1/charts/09e899079ad4/data \
-H "Authorization: Bearer $VIRALCHART_KEY"claude mcp add --transport http viralchart https://viral-chart.com/mcp \
--header "Authorization: Bearer $VIRALCHART_KEY"60 requests a minute per key; over that you get 429 with Retry-After. Up to 5 keys per account, made on your account page and shown once. Without Max, the data route answers 402 with a link to the plans. The numbers describe a chart its publisher owns, and every file carries a license note.
More from Social Capital
All 41
Other giants using a line chart
All 295
Questions people ask
How far did Social Capital's "GLP-1 drug revenue comparison" chart travel?
92,855 views, 614 likes, 64 reposts and 172 saves on X, read Oct 14, 2026. A normal post from @socialcapital gets about 4.1K views.
What kind of chart is it?
A line chart. GLP-1 drug revenues surpass AI companies.
Can I use Social Capital's chart?
Use the format, not the picture. The chart, logo and design belong to Social Capital. ViralChart redraws the chart type with your numbers and words, and credits the original publisher.